Anu Mahadevan Selected Research

Hyperphagia (Overeating)

6/2013

A novel fluorophosphonate inhibitor of the biosynthesis of the endocannabinoid 2-arachidonoylglycerol with potential anti-obesity effects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anu Mahadevan Research Topics

Disease

4	Hypothermia 02/2011 - 01/2006
3	Hyperalgesia 04/2015 - 02/2011
3	Pain (Aches) 03/2013 - 11/2009
2	Inflammation (Inflammations) 04/2015 - 02/2011
2	Obesity 06/2013 - 11/2012
2	Edema (Dropsy) 03/2013 - 02/2011
2	Reperfusion Injury 09/2012 - 04/2012
1	Cough 01/2023
1	Tobacco Use Disorder (Nicotine Dependence) 10/2020
1	Neuralgia (Stump Neuralgia) 04/2015
1	Breast Neoplasms (Breast Cancer) 10/2014
1	Neoplasm Metastasis (Metastasis) 10/2014
1	Neoplasms (Cancer) 10/2014
1	Body Weight (Weight, Body) 06/2013
1	Hyperphagia (Overeating) 06/2013
1	Neuroblastoma 06/2013
1	Infarction (Infarctions) 09/2012
1	Stroke (Strokes) 09/2012
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 09/2012
1	Neuroinflammatory Diseases 03/2012
1	Hemorrhage 09/2011
1	Visceral Pain 11/2009
1	Catalepsy 11/2008
1	Pathologic Processes 01/2008
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2006
1	Multiple Sclerosis 01/2006

Drug/Important Bio-Agent (IBA)

7	CannabinoidsIBA 04/2015 - 02/2011
5	Dronabinol (THC)FDA LinkGeneric 10/2014 - 11/2008
3	Monoacylglycerol LipasesIBA 04/2015 - 09/2011
3	JZL 184IBA 04/2015 - 09/2011
3	SulfonamidesIBA 11/2012 - 01/2011
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 04/2015 - 09/2011
2	CB2 Cannabinoid ReceptorIBA 04/2015 - 02/2011
2	Diclofenac (SR 38)FDA LinkGeneric 04/2015 - 09/2011
2	Analgesics (Analgesic Drugs)IBA 04/2015 - 09/2011
2	EndocannabinoidsIBA 06/2013 - 01/2008
2	anandamide (arachidonylethanolamide)IBA 01/2008 - 01/2006
1	Adenosine Triphosphate (ATP)IBA 01/2023
1	NeuropeptidesIBA 01/2023
1	Nicotine FDA Link 10/2020
1	SR 144528IBA 04/2015
1	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 04/2015
1	RimonabantIBA 04/2015
1	SteroidsIBA 04/2015
1	gamma-Aminobutyric Acid (GABA)IBA 04/2015
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 04/2015
1	IsoenzymesIBA 04/2015
1	CannabidiolIBA 10/2014
1	resorcinol (resorcin)IBA 10/2014
1	IonomycinIBA 06/2013
1	1- ((fluoro(methyl)phosphoryl)oxy)- 3- isopropoxypropan- 2- yl oleateIBA 06/2013
1	glyceryl 2-arachidonate (2-arachidonoylglycerol)IBA 06/2013
1	CarrageenanIBA 03/2013
1	pyrazoleIBA 11/2012
1	TRPV Cation ChannelsIBA 09/2012
1	5-HT1A Serotonin ReceptorIBA 09/2012
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 09/2012
1	Serotonin ReceptorsIBA 09/2012
1	capsazepineIBA 09/2012
1	TRPV1 receptorIBA 09/2012
1	LigandsIBA 03/2012
1	Proton Pump InhibitorsIBA 09/2011
1	Omeprazole (Prilosec)FDA LinkGeneric 09/2011
1	CytokinesIBA 09/2011
1	Cyclooxygenase InhibitorsIBA 09/2011
1	Formaldehyde (Formol)FDA Link 02/2011
1	3- (2- hydroxy- 4- (1,1- dimethylheptyl)phenyl)- 4- (3- hydroxypropyl)cyclohexanolIBA 02/2011
1	O 3223IBA 02/2011
1	(6aR,10aR)- 3- (1- methansulfonylamino- 4- hexyn- 6- yl)6a,7,10,10a- tetrahydro- 6,6,9- trimethyl- 6H- dibenzo(b,d)pyranIBA 01/2011
1	Cannabinoid Receptor AgonistsIBA 01/2011
1	Acetic Acid (Vinegar)FDA LinkGeneric 11/2009

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 10/2020
1	Analgesia 01/2006